BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. [https://doi.org/10.3322/caac.21332]. PMID:26742998
   PubMed Web of Science ®Google Scholar
• Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–23. [https://doi.org/10.1056/NEJMoa1003466]. PMID:20525992
   PubMed Web of Science ®Google Scholar
• Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54. [https://doi.org/10.1056/NEJMoa1200690]. PMID:22658127
   PubMed Web of Science ®Google Scholar
• Farren MR, Mace TA, Geyer S, Mikhail S, Wu C, Ciombor K, Tahiri S, Ahn D, Noonan AM, Villalona-Calero M, et al. Systemic immune activity predicts overall survival in treatment-naïve patients with metastatic pancreatic cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:2565–74. [https://doi.org/10.1158/1078-0432.CCR-15-1732]
   PubMed Web of Science ®Google Scholar
• Diana A, Wang LM, D'Costa Z, Allen P, Azad A, Silva MA, Soonawalla Z, Liu S, McKenna WG, Muschel RJ, et al. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7(27):40992–1004. [https://doi.org/10.18632/oncotarget.10038]. PMID:27329602
   PubMed Web of Science ®Google Scholar
• Daley D, Zambirinis CP, Seifert L, Akkad N, Mohan N, Werba G, Barilla R, Torres-Hernandez A, Hundeyin M, Mani VR, et al. γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation. Cell. 2016;166:1485–1499.e15. [https://doi.org/10.1016/j.cell.2016.07.046]. PMID:27569912
   PubMed Web of Science ®Google Scholar
• Chang Q, Jurisica I, Do T, Hedley DW. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer. Cancer Res. 2011;71:3110–20. [https://doi.org/10.1158/0008-5472.CAN-10-4049]. PMID:21343390
   PubMed Web of Science ®Google Scholar
• Hasmim M, Messai Y, Ziani L, Thiery J, Bouhris JH, Noman MZ, Chouaib S. Critical role of tumor microenvironment in shaping NK cell functions: implication of hypoxic stress. Front Immunol. 2015;6:482. [https://doi.org/10.3389/fimmu.2015.00482]. PMID:26441986
   PubMed Web of Science ®Google Scholar
• Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, Buart S, Berchem G, Romero P, Mami-Chouaib F, et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 2011;71:5976–86. [https://doi.org/10.1158/0008-5472.CAN-11-1094]. PMID:21810913
   PubMed Web of Science ®Google Scholar
• Noman MZ, Buart S, Van Pelt J, Richon C, Hasmim M, Leleu N, Suchorska WM, Jalil A, Lecluse Y, El Hage F, et al. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J Immunol. 2009;182:3510–21. [https://doi.org/10.4049/jimmunol.0800854]. PMID:19265129
   PubMed Web of Science ®Google Scholar
• Kitayama J, Atomi Y, Nagawa H, Kuroda A, Mutoh T, Minami M, Juji T. Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer. Clin Exp Immunol. 1993;93:442–7. [https://doi.org/10.1111/j.1365-2249.1993.tb08198.x]. PMID:8370173
   PubMed Web of Science ®Google Scholar
• Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9(5):e94357. [https://doi.org/10.1371/journal.pone.0094357]. eCollection 2014.
   Google Scholar
• Di Marco Barros R, Roberts NA, Dart RJ, Vantourout P, Jandke A, Nussbaumer O, Deban L, Cipolat S, Hart R, Iannitto ML, et al. Epithelia use butyrophilin-like molecules to shape organ-specific γδ t cell compartments. Cell. 2016;167:203–218.e17. [https://doi.org/10.1016/j.cell.2016.08.030]. PMID:27641500
   PubMed Web of Science ®Google Scholar
• Nicol AJ, Tokuyama H, Mattarollo SR, Hagi T, Suzuki K, Yokokawa K, Nieda M. Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. Br J Cancer. 2011;105:778–86. [https://doi.org/10.1038/bjc.2011.293]. PMID:21847128
   PubMed Web of Science ®Google Scholar
• Corvaisier M, Moreau-Aubry A, Diez E, Bennouna J, Mosnier JF, Scotet E, Bonneville M, Jotereau F. V gamma 9 V delta 2 T cell response to colon carcinoma cells. J Immunol. 2005;175:5481–8. [https://doi.org/10.4049/jimmunol.175.8.5481]. PMID:16210656
   PubMed Web of Science ®Google Scholar
• Cordova A, Toia F, La Mendola C, Orlando V, Meraviglia S, Rinaldi G, Todaro M, Cicero G, Zichichi L, Donni PL, et al. Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas. PloS One. 2012;7:e49878. [https://doi.org/10.1371/journal.pone.0049878]. PMID:23189169
   PubMed Web of Science ®Google Scholar
• Gober H-J, Kistowska M, Angman L, Jenö P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med. 2003;197:163–8. [https://doi.org/10.1084/jem.20021500]. PMID:12538656
   PubMed Web of Science ®Google Scholar
• Li J, Herold MJ, Kimmel B, Müller I, Rincon-Orozco B, Kunzmann V, Herrmann T. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells. J Immunol. 2009;182:8118–24. [https://doi.org/10.4049/jimmunol.0900101]. PMID:19494338
   PubMed Web of Science ®Google Scholar
• Benzaïd I, Mönkkönen H, Stresing V, Bonnelye E, Green J, Mönkkönen J, Touraine JL, Clézardin P. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res. 2011;71:4562–72. [https://doi.org/10.1158/0008-5472.CAN-10-3862]. PMID:21646473
   PubMed Web of Science ®Google Scholar
• Märten A, von Lilienfeld-Toal M, Büchler MW, Schmidt J. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. Int J Cancer J Int Cancer. 2006;119:2359–65. [https://doi.org/10.1002/ijc.22186]
   PubMed Web of Science ®Google Scholar
• McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell. 2014;25:621–37. [https://doi.org/10.1016/j.ccr.2014.03.014]. PMID:24823639
   PubMed Web of Science ®Google Scholar
• Kabelitz D, Wesch D, Pitters E, Zöller M. Characterization of tumor reactivity of human V gamma 9 V delta 2 gamma delta T cells in vitro and in SCID mice in vivo. J Immunol. 2004;173:6767–76. [https://doi.org/10.4049/jimmunol.173.11.6767]. PMID:15557170
   PubMed Web of Science ®Google Scholar
• Harly C, Guillaume Y, Nedellec S, Peigné CM, Mönkkönen H, Mönkkönen J, Li J, Kuball J, Adams EJ, Netzer S, et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood. 2012;120:2269–79. [https://doi.org/10.1182/blood-2012-05-430470]. PMID:22767497
   PubMed Web of Science ®Google Scholar
• Rhodes DA, Chen HC, Price AJ, Keeble AH, Davey MS, James LC, Eberl M, Trowsdale J. Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin. J Immunol. 2015;194(5):2390–8. [https://doi.org/10.4049/jimmunol.1401064]. PMID:25637025
   PubMed Web of Science ®Google Scholar
• Benyamine A, Le Roy A, Mamessier E, Gertner-Dardenne J, Castanier C, Orlanducci F, Pouyet L, Goubard A, Collette Y, Vey N, et al. BTN3A molecules considerably improve Vγ9Vδ2 T cells-based immunotherapy in acute myeloid leukemia. Oncoimmunology. 2016;5:e1146843. [https://doi.org/10.1080/2162402X.2016.1146843]. PMID:27853633
   PubMed Web of Science ®Google Scholar
• Compte E, Pontarotti P, Collette Y, Lopez M, Olive D. Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells. Eur J Immunol. 2004;34:2089–99. [https://doi.org/10.1002/eji.200425227]. PMID:15259006
   PubMed Web of Science ®Google Scholar
• Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I, Madore J, Delvoye N, Mes-Masson AM, Provencher DM, et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PloS One. 2012;7:e38541. [https://doi.org/10.1371/journal.pone.0038541]. PMID:22685580
   PubMed Web of Science ®Google Scholar
• Cubillos-Ruiz JR, Martinez D, Scarlett UK, Rutkowski MR, Nesbeth YC, Camposeco-Jacobs AL, Conejo-Garcia JR. CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget. 2010;1:329–38. [https://doi.org/10.18632/oncotarget.165]. PMID:21113407
   PubMed Web of Science ®Google Scholar
• Zhu M, Yan C, Ren C, Huang X, Zhu X, Gu H, Wang M, Wang S, Gao Y, Ji Y, et al. Exome array analysis identifies variants in SPOCD1 and BTN3A2 that affect risk for gastric cancer. Gastroenterology. 2017;152(8):2011–2021. [https://doi.org/10.1053/j.gastro.2017.02.017]. [Epub 2017 Feb 27]
   Google Scholar
• Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010;39:425–35. [https://doi.org/10.1097/MPA.0b013e3181c15963]. PMID:20418756
   PubMed Web of Science ®Google Scholar
• Elsässer HP, Lehr U, Agricola B, Kern HF. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64:201–7. [https://doi.org/10.1007/BF02915113]. PMID:8287116
   PubMedGoogle Scholar
• Elsässer HP, Lehr U, Agricola B, Kern HF. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61:295–306. [https://doi.org/10.1007/BF02890431]. PMID:1348891
   PubMedGoogle Scholar
• Duconseil P, Gilabert M, Gayet O, Loncle C, Moutardier V, Turrini O, Calvo E, Ewald J, Giovannini M, Gasmi M, et al. Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma. Am J Pathol. 2015;185(4):1022–32. [https://doi.org/10.1016/j.ajpath.2014.11.029]. PMID:25765988
   PubMed Web of Science ®Google Scholar
• Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, et al. Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity. Oncoimmunology. 2017;6:e1278099. [https://doi.org/10.1080/2162402X.2016.1278099]. PMID:28405500
   PubMed Web of Science ®Google Scholar
• Kilcollins AM, Li J, Hsiao C-HC, Wiemer AJ. HMBPP analog prodrugs bypass energy-dependent uptake to promote efficient BTN3A1-mediated malignant cell lysis by Vγ9Vδ2 T lymphocyte effectors. J Immunol Baltim Md 1950. 2016;197:419–28.
   Google Scholar
• Sandstrom A, Peigné CM, Léger A, Crooks JE, Konczak F, Gesnel MC, Breathnach R, Bonneville M, Scotet E, Adams EJ. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity. 2014;40:490–500. PMID:24703779
   PubMed Web of Science ®Google Scholar
• Wang H, Henry O, Distefano MD, Wang YC, Räikkönen J, Mönkkönen J, Tanaka Y, Morita CT. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. J Immunol. 2013;191:1029–42. PMID:23833237
   PubMed Web of Science ®Google Scholar
• Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult M-L, Chetaille B, Firaguay G, Pastor S, Guillaume Y, Wang Q, et al. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur J Immunol. 2011;41:3443–54. PMID:21918970
   PubMed Web of Science ®Google Scholar
• Palakodeti A, Sandstrom A, Sundaresan L, Harly C, Nedellec S, Olive D, Scotet E, Bonneville M, Adams EJ. The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J Biol Chem. 2012;287:32780–90. PMID:22846996
   PubMed Web of Science ®Google Scholar
• Liu Z, Guo B, Lopez RD. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer. J Gastroenterol Hepatol. 2009;24:900–11. PMID:19175829
   PubMed Web of Science ®Google Scholar
• Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezène P, Dusetti NJ, Loncle C, Calvo E, Turrini O, et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2013;110:3919–24. PMID:23407165
   PubMed Web of Science ®Google Scholar
• Charpin C, Tavassoli F, Secq V, Giusiano S, Villeret J, Garcia S, Birnbaum D, Bonnier P, Lavaut MN, Boubli L, et al. Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma. Int J Cancer J Int Cancer. 2012;131:E236–243.
   PubMed Web of Science ®Google Scholar
• Giusiano S, Secq V, Carcopino X, Carpentier S, Andrac L, Lavaut MN, Allasia C, Bonnier P, Iovanna JL, Garcia S, et al. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk. Int J Oncol. 2010;36:889–98. PMID:20198333
   PubMed Web of Science ®Google Scholar
• Gertner J, Wiedemann A, Poupot M, Fournié JJ. Human gammadelta T lymphocytes strip and kill tumor cells simultaneously. Immunol Lett. 2007;110:42–53. [https://doi.org/10.1016/j.imlet.2007.03.002]. PMID:17451812
   PubMed Web of Science ®Google Scholar
• Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281–308. [https://doi.org/10.1038/nprot.2013.143]. PMID:24157548
   PubMed Web of Science ®Google Scholar
• Goswami CP, Nakshatri H. PROGgene: gene expression based survival analysis web application for multiple cancers. J Clin Bioinforma. 2013;3:22.[https://doi.org/10.1186/2043-9113-3-22]. PMID:24165311
   PubMedGoogle Scholar